Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
- 1 August 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (8), 1474-1478
- https://doi.org/10.1161/01.atv.0000134378.86443.cd
Abstract
Background— Atherosclerosis is an immunoinflammatory disease. Here we examined the role of leukocyte-derived interleukin 10 (IL-10) on advanced atherosclerosis development in low-density lipoprotein receptor knockout (LDLr−/−) mice. Methods and Results— Bone marrow cells harvested from C57BL/6 IL-10−/− and IL-10+/+ mice were transplanted into irradiated male LDLr−/− mice. Four weeks after transplantation, mice were fed a high-fat cholate-free diet for 14 weeks. Despite no differences in weights, serum total, and HDL-cholesterol levels between the 2 groups, IL-10 deficiency in leukocytes induced a >2-fold increase in lesion development in the thoracic aorta compared with controls. We also found a significant 35% increase in aortic root lesion area of IL-10−/− mice compared with IL-10+/+ mice. Furthermore, IL-10 deficiency led to a marked increase in lymphocyte and macrophage accumulation associated with a significant reduction in collagen accumulation. Finally, transfer of IL-10−/− splenocytes to LDLr−/− mice resulted in a 3-fold increase in lesion size in the aortic sinus compared with mice transplanted with IL-10+/+ splenocytes. Conclusion— IL-10 expressed by leukocytes prevents exaggerated advanced atherosclerosis development and plays a critical role in modulation of cellular and collagen plaque composition, at least in part, through a modulation of the systemic immune response.Keywords
This publication has 18 references indexed in Scilit:
- Type 1 T-regulatory cells: their role in the control of immune responses1Transplantation, 2003
- Inflammation in atherosclerosisNature, 2002
- Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 2002
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque ProgressionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Attenuation of atherogenesis by systemic and local adenovirus‐mediated gene transfer of interleukin‐10 in LDLr ‐/‐ MiceThe FASEB Journal, 2001
- In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.JCI Insight, 1997
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.JCI Insight, 1996
- Endogenous Interleukin 10 Prevents Apoptosis in Macrophages during Salmonella InfectionBiochemical and Biophysical Research Communications, 1995
- Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human MonocytesJournal of Biological Chemistry, 1995